Nalmefene Smoking Cessation Study

NCT00202696 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: nalmefene
OTHER: Placebo

Sponsor

Somaxon Pharmaceuticals